Cellino Biotech Secures ARPA-H Funding to Advance Scalable Biomanufacturing Technology for Regenerative Medicine

Cellino Biotech, Inc. has been awarded up to $25 million by the Advanced Research Projects Agency for Health (ARPA-H), part …

Continue ›››

AI-powered R&D Marketplace Scientist.com Streamlines Access to Drug Discovery and Sequencing Technologies

Scientist.com has announced a partnership with Evotec SE, aimed at integrating Evotec’s advanced drug discovery and development services into Scientist.com’s …

Continue ›››

Relay Therapeutics Reports Positive Early Results for Breast Cancer Drug

Relay Therapeutics has reported encouraging results from a small clinical trial of its experimental breast cancer drug, RLY-2608, which demonstrated …

Continue ›››

BIOCAPTIVA Secures US Patent for Advanced DNA-Extraction Technology in Cancer Management

BIOCAPTIVA, a biotech company based in Edinburgh, has been granted its first US patent for a liquid biopsy technology designed …

Continue ›››

MGI Introduces New CycloneSEQ Nanopore Sequencing Products

MGI Tech Co., Ltd., a global developer of life science technologies, has launched two new nanopore sequencing products, CycloneSEQ-WT02 and …

Continue ›››

Superluminal Medicines Raises $120 Million to Advance GPCR-Targeted Drug Discovery

Superluminal Medicines, Inc. has raised $120 million in a Series A funding round led by RA Capital Management, with participation …

Continue ›››

Rethinking Clinical Trials: Tim Smith on Medable’s Approach to Speed and Efficiency

As the demand for decentralized and hybrid clinical trials rises, Medable Inc. is positioning itself at the forefront of this …

Continue ›››

Eli Lilly Partners with Genetic Leap in $409 Million AI-Driven Drug Discovery Deal

Eli Lilly has announced a partnership with Genetic Leap, a biotech company specializing in RNA-targeted drug discovery using AI models. …

Continue ›››

ETH Zurich’s Flexible Brain Probes: A Safer Twist in the BCI Journey

Neuralink recently captured the public's attention with the implantation of its brain chip in a second patient, allowing the person …

Continue ›››

Proscia Expands Concentriq Platform with Real-World Data to Enhance Precision Medicine

Proscia has announced a new real-world data offering on its Concentriq platform, integrating over 10 million de-identified pathology images with …

Continue ›››

BioAge Labs Files for IPO with Focus on Anti-Aging Therapeutics and Metabolic Diseases

BioAge Labs, a clinical-stage biopharmaceutical company specializing in anti-aging and metabolic disease therapeutics, has filed for an initial public offering …

Continue ›››

12 Useful Mobile Apps For Life Scientists

(Updated: 2.09.2024) Nowadays mobile devices are ubiquitous with an estimated number of smartphones and tablet PCs to exceed two billion …

Continue ›››